Depression has been treated with a number of blockbuster drugs, but these have been severely impacted by patent expiration. At its peak in 2003, the branded depression drug market was worth almost $15 billion, but by 2012 the market had lost almost a third of its value, with sales of $9.560 billion reported that year […]
written on 17.04.2014
The Challenges for Antidepressant Medications
